Ginkgetin inhibits the growth of DU−145 prostate cancer cells through inhibition of signal transducer and activator of transcription 3 activity

Publisher： John Wiley & Sons Inc

E-ISSN： 1349-7006|106|4|413-420

ISSN： 1347-9032

Source： Cancer Science, Vol.106, Iss.4, 2015-04, pp. : 413-420

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase I study of OPB‐51602, an oral inhibitor of signal transducer and activator of transcription 3, in patients with relapsed/refractory hematological malignancies

By  

Cancer Science, Vol. 106, Iss. 7, 2015-07 ,pp. : 896-901

John Wiley & Sons Inc

Access to resources Recommend Favorite

Tumor‐suppressive microRNA‐145 induces growth arrest by targeting SENP1 in human prostate cancer cells

By  

Cancer Science, Vol. 106, Iss. 4, 2015-04 ,pp. : 375-382

John Wiley & Sons Inc

Access to resources Recommend Favorite

Magnolol inhibits growth of gallbladder cancer cells through the p53 pathway

By  

Cancer Science, Vol. 106, Iss. 10, 2015-10 ,pp. : 1341-1350

John Wiley & Sons Inc

Access to resources Recommend Favorite

Therapeutic advances in BIG3‐PHB2 inhibition targeting the crosstalk between estrogen and growth factors in breast cancer

By  

Cancer Science, Vol. 106, Iss. 5, 2015-05 ,pp. : 550-558

John Wiley & Sons Inc

Access to resources Recommend Favorite

Fibrinogen‐derived fibrinostatin inhibits tumor growth through anti‐angiogenesis

By  

Cancer Science, Vol. 106, Iss. 11, 2015-11 ,pp. : 1596-1606

John Wiley & Sons Inc

Access to resources Recommend Favorite